Skip to content

Effect of Ultra-processed Versus Unprocessed Diets on Energy Metabolism

Effect of Ultra-processed Versus Unprocessed Diets on Energy Metabolism

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05290064
Enrollment
38
Registered
2022-03-22
Start date
2022-11-24
Completion date
2025-08-15
Last updated
2026-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Diet, Obesity

Keywords

Body Weight, Food Intake, Fat, Calories, Body Mass Index

Brief summary

Protocol Number: 22DK0002 Title: Effects of Ultra-processed versus Unprocessed Diets on Energy Metabolism Background: Many diets worldwide include both processed and unprocessed foods. Researchers want to study the effects these foods have on a person s health. Objective: To study how different diets affect a person s health and metabolism. Eligibility: Adults aged 18 60 without diabetes who have stable weight and can exercise. Design: Participants will be screened with: Medical history Physical exam Heart tests Resting energy expenditure (to determine calorie needs) Blood and urine tests 20-minute stationary bicycle session Food, diet, and mental health questionnaires Participants will stay at NIH for 4 weeks. They will receive 3 meals a day and may eat as little or as much as they want. The diet will change each week. Their weight will be recorded daily. They will ride a stationary bicycle daily. Each week, they will do the following: Spend 1 day in a special room that assesses their metabolism Have 24-hour urine collections Give skin and fecal samples Repeat some screening tests Have scans to measure body fat Complete computerized behavior tasks Wear an activity monitor to track physical activity Wear a glucose monitor. A sensor will be inserted under the skin with a small needle. It will be replaced weekly. Take taste tests. They will swish water and flavored liquids around in their mouth and pick which ones had a non-neutral taste. They will also compare liquids for which ones taste better. Participation will last for 4 weeks. Sponsoring Institution: National Institute of Diabetes and Digestive and Kidney Diseases ...

Detailed description

This is a randomized crossover study of adult volunteers to determine the health effects of four different diets varying in non-beverage energy density, hyperpalatable foods, as well as the degree, extent, and purpose of processing according to the NOVA classification system. Objectives/Endpoints: Primary Aim: To determine differences in health effects during four 1-week test diets. Secondary Aims: To determine differences in mean eating rate (grams per minute) and palatability of meals between the four 1-week test diets. Exploratory Aims: Several exploratory measurements are planned to help comprehensively phenotype the effects of the test diets and are intended to be hypothesis-generating.

Interventions

OTHERUltra-processed food, high energy density (UPF HL)

Ultra-processed diet that is high in non-beverage energy density and low in hyperpalatable foods

OTHERUltra-processed food, both low (UPF LL)

Ultra-processed diet that is low in both non-beverage energy density and hyperpalatable foods

OTHERUltra-processed food, both high (UPF HH)

Ultra-processed diet that is high in both non-beverage energy density and hyperpalatable foods

OTHERUnprocessed food diet (UNF LL)

Unprocessed diet that is low in both non-beverage energy density and hyperpalatable foods

Sponsors

National Institutes of Health Clinical Center (CC)
Lead SponsorNIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Provision of signed and dated informed consent form * Adults age 18-60 years, male and female * Weight stable (\< +/- 5 % body weight change over past 6 months) as determined by volunteer report * Body mass index (BMI) \> =20 kg/m2 * Body weight \> = 53 kg * Able to complete daily bouts of stationary cycling at a moderate rate and intensity with a HR equal to or greater than 0.3(SqrRoot) (220-age-HRrest)+HRrest but not exceeding 0.4(SqrRoot) (220-age-HRrest)+HRrest and no signs of arrhythmia * Willingness to comply with all study procedures and Lifestyle Considerations for the duration of the study per the discretion of the PI.

Exclusion criteria

An individual who meets any of the following criteria will be excluded from participation in this study: * Evidence of diseases or conditions that may influence appetite (e.g., cancer, diabetes, alterations of smell or taste post COVID-19), or other conditions at the discretion of the PI and/or study team). * Taking prescription medications or other drugs that may influence appetite (including, but not limited to, diet/weight-loss medication or other medications at the discretion of the PI and/or study team) * Positive pregnancy test or lactation as determined by volunteer report (women only) * Participating in a regular exercise program (\> 2h/week of vigorous activity) as determined by volunteer report * Hematocrit \< 37% (women only) * Hematocrit \< 40% (men only) * Caffeine consumption \> 300 mg/day as determined by volunteer report * Alcohol consumption \> 3 drinks per day for men or \> 2 drinks per day for women as determined by volunteer report * Regular use of tobacco (smoking or chewing), amphetamines, cocaine, heroin, or marijuana over past 6 months as determined by volunteer report. Subjects may also be excluded based on a urine drug test. * Psychological conditions as determined by volunteer report such as (but not limited to) eating disorders, depression, bipolar disorders, that would be incompatible with safe and successful participation in this study, as determined by investigators * Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, food allergies) or a reported dislike of a significant fraction of the study foods * Volunteers unwilling or unable to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Energy Intake (kcal Per Day)Four 1-week dietsEnergy intake averaged over 7 days for each diet, measured in kilocalories (kcal) per day. Primary comparisons will be between UPF HH \&amp; UPF HL, UPF HL \&amp; UPF LL, UPF LL \&amp; UNF LL, UPF HH \&amp; UNF LL.

Secondary

MeasureTime frameDescription
Meal Eating Rate (Grams Per Minute)Four 1-week dietsThis will be determined by the measured duration of the meals along with the measured mass of food consumed.
Meal PalatabilityFour 1-week dietsMeal Palatability will be measured via questionnaires using visual analogue scales. The range of VAS is 0-100, where 0 = "Not at all palatable" and 100 = "Extremely palatable"

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORValerie L Darcey

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Participant flow

Recruitment details

Adult subjects were recruited to the study via the NIH Patient Recruitment and Public Liaison Office from 11/24/2022 to 8/15/2025.

Baseline characteristics

Characteristic
Age, Continuous36.31 year
STANDARD_DEVIATION 11.27
Body Mass Index33.28 kilogram per square meter
STANDARD_DEVIATION 9.58
Body Weight100.46 kilogram
STANDARD_DEVIATION 25.03
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
6 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
2 Participants
Race (NIH/OMB)
More than one race
5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
White
16 Participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 360 / 360 / 360 / 36
other
Total, other adverse events
1 / 360 / 360 / 361 / 36
serious
Total, serious adverse events
0 / 360 / 360 / 360 / 36

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 13, 2026